Clinical Trial Update: This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating long-term safety and tolerability of brivaracetam in epilepsy has completed with open-label extension data available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB PHARMA Inc. (US) | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2018-12-05